Beranda524372 • BOM
add
Orchid Pharma Ltd
Tutup sebelumnya
₹747,40
Rentang hari
₹747,95 - ₹768,90
Rentang tahun
₹603,80 - ₹1.998,00
Kapitalisasi pasar
38,18 M INR
Volume Rata-Rata
15,87 rb
Rasio P/E
-
Hasil dividen
-
Bursa utama
NSE
Berita pasar
Keuangan
Laporan Pendapatan
Pendapatan
Laba bersih
(INR) | Mar 2025info | Perubahan Y/Y |
---|---|---|
Pendapatan | 2,37 M | 9,39% |
Biaya operasional | 803,51 jt | 65,13% |
Laba bersih | 222,95 jt | -33,50% |
Margin laba bersih | 9,39 | -39,18% |
Penghasilan per saham | 4,40 | — |
EBITDA | 277,48 jt | -6,06% |
Tarif pajak efektif | -0,18% | — |
Neraca
Total aset
Total liabilitas
(INR) | Mar 2025info | Perubahan Y/Y |
---|---|---|
Investasi tunai jangka pdk | 1,80 M | 4.868,40% |
Total aset | 16,88 M | 8,63% |
Total liabilitas | 4,21 M | 9,42% |
Total ekuitas | 12,67 M | — |
Saham yang beredar | 50,67 jt | — |
Harga terhadap nilai buku | 2,99 | — |
Tingkat pengembalian aset | — | — |
Tingkat pengembalian modal | 3,38% | — |
Arus Kas
Perubahan kas bersih
(INR) | Mar 2025info | Perubahan Y/Y |
---|---|---|
Laba bersih | 222,95 jt | -33,50% |
Kas dari operasi | — | — |
Kas dari investasi | — | — |
Kas dari pembiayaan | — | — |
Perubahan kas bersih | — | — |
Arus kas bebas | — | — |
Tentang
Orchid Pharma Limited is an Indian pharmaceutical company based in Chennai, founded on 1 July 1992. As of 2024, it was among the top fortune 500 Indian companies by market capitalization. Orchid Pharma is the only pharma company in India to have discovered a New Drug Enmetazobactam which is now approved in United States, Europe and India. Wikipedia
Didirikan
1992
Situs
Karyawan
871